Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 54, 2020 - Issue 1
Journal homepage
1,866
Views
11
CrossRef citations to date
0
Altmetric
Articles

Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden

Gincy GeorgeTranslational Oncology and Urology Research, King’s College London, London, UK; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-0605-5507View further author information
ORCID Icon,
Hans GarmoTranslational Oncology and Urology Research, King’s College London, London, UK; ORCID Iconhttp://orcid.org/0000-0001-7181-7083View further author information
ORCID Icon,
Sarah RudmanMedical Oncology, Guy's and St Thomas' Foundation Trust, London, UK; View further author information
,
Lars HolmbergTranslational Oncology and Urology Research, King’s College London, London, UK; ;Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; View further author information
,
David RobinsonDepartment of Urology, Ryhov Hospital, Jönköping, Sweden; View further author information
,
Pär StattinDepartment of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; View further author information
,
Jan AdolfssonDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, SwedenView further author information
&
Mieke Van HemelrijckTranslational Oncology and Urology Research, King’s College London, London, UK; ORCID Iconhttp://orcid.org/0000-0002-7317-0858View further author information
ORCID Icon show all
Pages 20-26 | Received 27 Jun 2019, Accepted 04 Dec 2019, Published online: 16 Dec 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rolf Gedeborg, Lars Lindhagen, Stacy Loeb, Johan Styrke, Hans Garmo & Pär Stattin. (2022) Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer. Scandinavian Journal of Urology 56:2, pages 104-111.
Read now

Articles from other publishers (10)

E. Lin, Hans Garmo, Emil Hagström, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius & Danielle Crawley. (2022) Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden. British Journal of Cancer 128:5, pages 814-824.
Crossref
Neil E. Fleshner, Shabbir M. H. Alibhai, Kim A. Connelly, Ilidio Martins, Bernhard J. Eigl, Himu Lukka & Armen Aprikian. (2023) Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review. Therapeutic Advances in Medical Oncology 15, pages 175883592311528.
Crossref
Rolf Gedeborg, Stacy Loeb, Johan Styrke, Ritva Kiiski‐Berggren, Hans Garmo & Pär Stattin. (2022) Susceptibility to SARS‐Cov ‐2 infection and risk for severe COVID ‐19 in patients with prostate cancer on androgen deprivation therapy . International Journal of Cancer 151:11, pages 1925-1934.
Crossref
Gincy George, Sarah Rudman, Louisa Fleure, Zoe Moon, Hans Garmo, Fidelma Cahill, Louis Fox, Charlotte Moss, Harriet Wylie, Anna Haire & Mieke Van Hemelrijck. (2022) Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer. Seminars in Oncology Nursing 38:4, pages 151236.
Crossref
E. Lin, Hans Garmo, Mieke Van Hemelrijck, Björn Zethelius, Pär Stattin, Emil Hagström, Jan Adolfsson & Danielle Crawley. (2022) Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes. JAMA Network Open 5:8, pages e2225600.
Crossref
Yashar Khoshkar, Marcus Westerberg, Jan Adolfsson, Anna Bill‐Axelson, Henrik Olsson, Martin Eklund, Olof Akre, Hans Garmo & Markus Aly. (2021) Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort. BJUI Compass 3:2, pages 173-183.
Crossref
Dominic Pilon, Joyce LaMori, Carmine Rossi, Mike Durkin, Isabelle Ghelerter, Xuehua Ke, Marie-Hélène Lafeuille, Lorie Ellis & Patrick Lefebvre. (2022) Medication adherence among patients with advanced prostate cancer using oral therapies. Future Oncology 18:2, pages 231-243.
Crossref
E. Lin, Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius & Danielle Crawley. (2021) Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study. BMC Cancer 21:1.
Crossref
Rui Yang, Zhenqi Lu, Xiaofeng Gu & Bo Dai. (2021) The Effect of an Information Support Program on Self-Efficacy of Prostate Cancer Patients during Hormonal Therapy. Asia-Pacific Journal of Oncology Nursing 8:6, pages 639-652.
Crossref
Rolf Gedeborg, Johan Styrke, Stacy Loeb, Hans Garmo & Pär Stattin. (2021) Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. PLOS ONE 16:10, pages e0255966.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.